Company & Leadership
Our Mission: Devoted to developing antibody-based therapies that allow pets with chronic diseases to thrive, not just survive.
Founding of Vetigenics
Pioneers in pet and human antibody therapeutics
Vetigenics scientific founders, Nicola Mason, BVetMed, Ph.D. and Don Siegel, Ph.D., M.D. of the University of Pennsylvania are internationally recognized leaders in veterinary medicine, immunotherapy, and phage display technology. Their complementary expertise naturally resulted in an unrivaled ability to generate and validate best in class antibody-based therapeutics to treat chronic diseases in both pets and humans.
Leadership Team

Nicola Mason B.Vet.Med, Ph.D., DACVIM (Internal Medicine), FCPP, MRCVS
Professor of Medicine at University of Pennsylvania, Founder of Vetigenics, and a pioneer in the field of Comparative Immunotherapy

Don Siegel Ph.D., M.D.
Professor of Pathology & Laboratory Medicine at University of Pennsylvania, Founder of Vetigenics, and globally recognized for groundbreaking contributions in Antibody Discovery and Cell Therapy

Adriann Sax
President, CEO and Founder of Vetigenics, with over 30 years of experience in BioPharma Leadership and Operations

Namrata Chand
Vice President of Business Development (BD) and Program Management with over 20 years of extensive experience in Biopharma BD and Operations

Hong Wang Ph.D.
Senior Scientist with over 30 years of leadership experience in Molecular Cell Biology, Genomics, Immunology, and Cancer Research

Marc Brillantes Ph.D.
Research Scientist with over 10 years of experience in Cellular Immunology and Immune System Research

Lexi Pusey
Quality and Laboratory Manager with 3+ years of experience in Program Management, Quality Processes, Standard Operating Procedures, and Procurement